SCHEMBL5131536

SCHEMBL5131536

CC(C=Cc1ccccc1)N(F)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.38
TDP1 Q9NUW8 3/20 0.37
EGFR P00533 1/20 0.37
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
GLA P06280 1/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.36
TSHR P16473 2/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5131533 1.00 CYP1A2 (0.39) CYP1A2CYP2C19TDP1EGFRPPARG
SCHEMBL6185894 0.78 MEN1 (0.39) CYP1A2CYP2C19TDP1PPARGPPARA
SCHEMBL3707871 0.72 PGR (0.47) CYP1A2CYP2C19TDP1MAPTALDH1A1
SCHEMBL27969407 0.72 CYP2C19 (0.42) CYP1A2CYP2C19TDP1EGFRPPARA
SCHEMBL13731859 0.72 CYP1A2 (0.44) CYP1A2CYP2C19TDP1EGFRGLA
SCHEMBL10973888 0.71 PPARA (0.47) TDP1EGFRPPARGPPARAMAPT
SCHEMBL10980321 0.71 PPARA (0.47) TDP1EGFRPPARGPPARAMAPT
SCHEMBL9058208 0.71 PPARA (0.47) TDP1EGFRPPARGPPARAMAPT
SCHEMBL31376582 0.71 CYP1A2 (0.42) CYP1A2CYP2C19TDP1EGFRPPARA
SCHEMBL31501587 0.71 CYP1A2 (0.42) CYP1A2CYP2C19TDP1EGFRPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008147547-A1 SUBSTITUTED HYDROXYETHYL AMINE COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2008-12-04 WO disclosed